NCT03822780View on ClinicalTrials.gov

Hydroxychloroquin (HCQ) in chILD of Genetic Defect

NARecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

December 30, 2025

Study Completion Date

July 30, 2026

Conditions
Surfactant Dysfunction
Interventions
DRUG

Hydroxychloroquin

Hydroxychloroquine Sulfate (HCQ, Quensyl) in a loading dose of 10 mg/kg\*d, p.o., bid. After the illness gradually alleviate to maintain dose between 5mg/kg\*d to 10mg/kg\*d, p.o., bid ; the maximum daily dose is 400mg.

Trial Locations (1)

201102

RECRUITING

Children's hospital of Fudan University, Shanghai

All Listed Sponsors
lead

Children's Hospital of Fudan University

OTHER